Dr Reddys Laboratories Ltd Share Price Today - Live Blog for February 12, 2026

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.17% gain, with the share price now at 1272.50. Notably, the stock's PE ratio stands at 19.2000, and its Return on Equity (ROE) is 16.0277.

Dr Reddys Laboratories Ltd observed a remarkable 0.17% surge in its share price and is presently trading at 1272.50. The increased investor interest is driving this surge.

Dr Reddys Laboratories Ltd share price surged by 0.17%. With its current market price standing at 1272.50 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd's shares experienced a 0.17% uptick, and they are currently valued at 1272.50, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1625 and an ROE of 16.0277.

With a remarkable 0.17% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at 1272.50. Notably, this stock has a Price-to-Earnings (PE) ratio of 19.2000, while the industry's PE ratio is 32.6061.

Dr Reddys Laboratories Ltd witnessed a substantial 0.17% increase in its share price and is currently trading at 1272.50. This remarkable performance has caught the eye of investors.

Dr Reddys Laboratories Ltd witnessed a substantial 0.15% increase in its share price and is currently trading at 1272.20. This remarkable performance has caught the eye of investors.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.09% drop, and it's now trading at 1269.10 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.09%. At this moment, it's actively trading at 1271.50, presenting an enticing opportunity for those in the market.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.15% upswing and is currently trading at 1272.20, indicating strong market sentiment.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.10% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at 1271.60 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.